By Elias Schisgall
Kymera Therapeutics Chief Operating Officer Jeremy Chadwick is retiring.
Chadwick will remain with the company as an adviser through the end of the year, Kymera said Monday. The biotechnology company did not give an exact date for his retirement.
Kymera also appointed Penny Carlson to serve as senior vice president, developmental operations. Carlson previously served as head of global clinical development operations at Takeda.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
June 08, 2026 18:17 ET (22:17 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.